A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Acute Myeloid Leukemia Real World Treatment Patterns
- Status
- WITHDRAWN
- Phase
- N/A
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
- Status
- RECRUITING
- Phase
- PHASE3
Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE3
Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
- Status
- COMPLETED
- Phase
- PHASE2